AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,624 | -29.8% | 106 | -19.7% | 0.00% | – |
Q2 2023 | $3,739 | +89.2% | 132 | +53.5% | 0.00% | – |
Q1 2023 | $1,976 | -2.3% | 86 | +19.4% | 0.00% | – |
Q4 2022 | $2,022 | -81.6% | 72 | -81.1% | 0.00% | -100.0% |
Q3 2022 | $11,000 | +37.5% | 381 | +3.8% | 0.00% | 0.0% |
Q2 2022 | $8,000 | +700.0% | 367 | +773.8% | 0.00% | – |
Q1 2022 | $1,000 | 0.0% | 42 | +7.7% | 0.00% | – |
Q4 2021 | $1,000 | -75.0% | 39 | -59.8% | 0.00% | -100.0% |
Q3 2021 | $4,000 | -20.0% | 97 | +12.8% | 0.00% | 0.0% |
Q2 2021 | $5,000 | +25.0% | 86 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $4,000 | 0.0% | 86 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $4,000 | +300.0% | 86 | +168.8% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 32 | +68.4% | 0.00% | – |
Q2 2020 | $1,000 | -95.2% | 19 | -96.8% | 0.00% | -100.0% |
Q1 2020 | $21,000 | -4.5% | 589 | +24.3% | 0.00% | +33.3% |
Q4 2019 | $22,000 | – | 474 | +4209.1% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 11 | -90.5% | 0.00% | -100.0% |
Q1 2019 | $7,000 | – | 116 | +625.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 16 | -84.0% | 0.00% | -100.0% |
Q3 2015 | $5,000 | +400.0% | 100 | +525.0% | 0.00% | +200.0% |
Q2 2015 | $1,000 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |